GI Disease

  • Nomi L. Traub
  • Richard B. Brooks


This chapter will discuss three distinct areas of gastrointestinal disease – acid peptic disorders, inflammatory bowel disease, and liver disease.


Abdominal Aortic Aneurysm Abdominal Aortic Aneurysm Peptic Ulcer Disease Transjugular Intrahepatic Portosystemic Shunt Short Bowel Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Ohmann C, Imhof M, Ruppert C, et al. Time–trends in the epidemiology of peptic ulcer ­bleeding. Scand J Gastroenterol. 2005;40:914-920.PubMedCrossRefGoogle Scholar
  2. 2.
    Kurata JH, Nogawa AN. Meta-analysis of risk factors for peptic ulcers. Nonsteroidal anti-inflammatory drugs, Helicobacter pylori, and smoking. J Clin Gastroenterol. 1997;24:2-12.PubMedCrossRefGoogle Scholar
  3. 3.
    Boey J, Choi SKY, Alagaratnam TT, Poon A. Risk stratification in perforated duodenal ulcers: a prospective validation of predictive factors. Ann Surg. 1987;205:22-26.PubMedCrossRefGoogle Scholar
  4. 4.
    Irvin TT. Mortality and perforated peptic ulcer: a case for risk stratification in elderly patients. Br J Surg. 1989;76:215-218.PubMedCrossRefGoogle Scholar
  5. 5.
    Cook DJ, Fuller HD, Guyatt GH, et al. Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med. 1994;330:377-381.PubMedCrossRefGoogle Scholar
  6. 6.
    Ng EKW, Lam YH, Sung JJY. Eradication of Helicobacter pylori prevents recurrence of ulcer after simple closure of duodenal ulcer perforation. Ann Surg. 2000;231:153-158.PubMedCrossRefGoogle Scholar
  7. 7.
    Malfertheiner P, Chan FKL, McColl KEL. Peptic ulcer disease. Lancet. 2009;374:1449-1461.PubMedCrossRefGoogle Scholar
  8. 8.
    Cosnes J, Beaugerie L, Carbonnel F, Gendre JP. Smoking cessation and the course of Crohn’s disease: an intervention study. Gastroenterology. 2001;120:1093-1099.PubMedCrossRefGoogle Scholar
  9. 9.
    Lindberg E, Tysk C, Andersson K, Jarnerot G. Smoking and inflammatory bowel disease. A case control study. Gut. 1988;29:352-357.PubMedCrossRefGoogle Scholar
  10. 10.
    Aberra FN, Lewis JD, Hass D, Rombeau JL, Osborne B, Lichtenstein GR. Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. Gastroenterology. 2003;125:320-327.PubMedCrossRefGoogle Scholar
  11. 11.
    Sewell JL, Mahadevan U. Infliximab and surgical complications: truth or perception? Gastroenterology. 2009;136:354-355.PubMedCrossRefGoogle Scholar
  12. 12.
    Evans JMM, McMahon AD, Murray FE, McDevitt DG, MacDonald TM. Non-steroidal ­anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease. Gut. 1997;40:619-622.PubMedGoogle Scholar
  13. 13.
    Metcalf AM. Elective and emergent operative management of ulcerative colitis. Surg Clin North Am. 2007;87:633-641.PubMedCrossRefGoogle Scholar
  14. 14.
    The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. Perioperative total parenteral nutrition in surgical patients. N Engl J Med. 1991;325:525-532.CrossRefGoogle Scholar
  15. 15.
    Miehsler W, Reinisch W, Valic E, et al. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut. 2004;53:542-548.PubMedCrossRefGoogle Scholar
  16. 16.
    Suman A, Barnes DS, Zein NN, Levinthal GN, Connor JT, Carey WD. Predicting outcome after cardiac surgery in patients with cirrhosis: a comparison of Child-Pugh and MELD scores. Clin Gastroenterol Hepatol. 2004;2:719-723.PubMedCrossRefGoogle Scholar
  17. 17.
    Tonnesen H, Rosenberg J, Nielsen HJ, et al. Effect of preoperative abstinence on poor ­postoperative outcome in alcohol misusers: randomized controlled trial. BMJ. 1999;318:1311-1316.PubMedGoogle Scholar
  18. 18.
    Kowdley KV, Brandhagen DJ, Gish RG, et al. Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry. Gastroenterology. 2005;129:494-503.PubMedGoogle Scholar
  19. 19.
    Murray JF, Dawson AM, Sherlock S. Circulatory changes in chronic liver disease. Am J Med. 1958;24:358-367.PubMedCrossRefGoogle Scholar
  20. 20.
    Puggioni A, Wong LL. A metaanalysis of laparoscopic cholecystectomy in patients with cirrhosis. J Am Coll Surg. 2003;197:921-926.PubMedCrossRefGoogle Scholar
  21. 21.
    Filsoufi F, Salzberg SP, Rahmanian PB, et al. Early and late outcome of cardiac surgery in patients with liver cirrhosis. Liver Transpl. 2007;13:990-995.PubMedCrossRefGoogle Scholar
  22. 22.
    Cohen SM, Te HS, Levitsky J. Operative risk of total hip and knee arthroplasty in cirrhotic patients. J Arthroplasty. 2005;20:460-466.PubMedCrossRefGoogle Scholar
  23. 23.
    Bush RL, Johnson ML, Hedayati N, Henderson WG, Lin PH, Lumsden AB. Performance of endovascular aortic aneurysm repair in high-risk patients: results from the Veterans Affairs National Surgical Quality Improvement Program. J Vasc Surg. 2007;45:227-233.PubMedCrossRefGoogle Scholar
  24. 24.
    Pronovost P, Dorman T, Sadovnikoff N, Garrett E, Breslow M, Rosenfeld B. The association between preoperative patient characteristics and both clinical and economic outcomes after abdominal aortic surgery. J Cardiothorac Vasc Anesth. 1999;13:549-554.PubMedCrossRefGoogle Scholar
  25. 25.
    Capussotti L, Viganò L, Giuliante F, Ferrero A, Giovannini I, Nuzzo G. Liver dysfunction and sepsis determine operative mortality after liver resection. Br J Surg. 2009;96:88-94.PubMedCrossRefGoogle Scholar
  26. 26.
    Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy – definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35:716-721.PubMedCrossRefGoogle Scholar
  27. 27.
    Teh SH, Nagorney DM, Stevens SR, et al. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology. 2007;132:1261-1269.PubMedCrossRefGoogle Scholar
  28. 28.
    Costa BP, Sousa FC, Serôdio M, Carvalho C. Value of MELD and MELD-based indices in surgical risk evaluation of cirrhotic patients: retrospective analysis of 190 cases. World J Surg. 2009;33:1711-1719.PubMedCrossRefGoogle Scholar
  29. 29.
    Schlenker C, Johnson S, Trotter JF. Preoperative transjugular intrahepatic portosystemic shunt (TIPS) for cirrhotic patients undergoing abdominal and pelvic surgeries. Surg Endosc. 2009;23:1594-1598.PubMedCrossRefGoogle Scholar
  30. 30.
    Friedman LS. The risk of surgery in patients with liver disease. Hepatology. 1999;29:1617-1623.PubMedCrossRefGoogle Scholar
  31. 31.
    Malik SM, Ahmad J. Preoperative risk assessment for patients with liver disease. Med Clin N Am. 2009;93:917-929.PubMedCrossRefGoogle Scholar
  32. 32.
    Millwala F, Nguyen GC, Thuluvath PJ. Outcomes of patients with cirrhosis undergoing non-hepatic surgery: risk assessment and management. World J Gastroenterol. 2007;13:4056-4063.PubMedGoogle Scholar

Suggested Reading

Acid-Peptic Disorders and Stress-Related Mucosal Disease

  1. ASHP. Therapeutic guidelines on stress ulcer prophylaxis. Am J Health Syst Pharm. 1999;56:347-379.Google Scholar
  2. Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med. 2008;36:296-327.PubMedCrossRefGoogle Scholar
  3. Gralnek IM, Barkun AN, Bardou M. Management of acute bleeding from a peptic ulcer. N Engl J Med. 2008;359:928-937.PubMedCrossRefGoogle Scholar
  4. Sung JJY, Barkun A, Kuipers EJ, Mössner J, Jensen DM, et al. Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding. Ann Intern Med. 2009;150:455-464.PubMedGoogle Scholar
  5. Sung JJY, Lau JYW, Ching JYL, Wu JCY, Lee YT, et al. Continuation of low-dose aspirin therapy in peptic ulcer bleeding. Ann Intern Med. 2010;152:1-9.PubMedGoogle Scholar

Inflammatory Bowel Disease

  1. Cohen JL, Strong SA, Hyman NH, et al. Practice parameters for the surgical treatment of ulcerative colitis. Dis Colon Rectum. 2005;48:1997-2009.PubMedCrossRefGoogle Scholar
  2. Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, et al. Infliximab, azathioprine, or combination therapy for Crohn’s disease. N Engl J Med. 2010;362:1383-1395.PubMedCrossRefGoogle Scholar
  3. Cullen JJ, Martin RF. Surgical Clinics of North America: Current Management of Inflammatory Bowel Disease. Philadelphia: W.B. Saunders; 2007:87.Google Scholar
  4. Marrero F, Qadeer MA, Lashner BA. Severe complications of inflammatory bowel disease. Med Clin N Am. 2008;92:671-686.PubMedCrossRefGoogle Scholar
  5. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417-429.PubMedCrossRefGoogle Scholar

Liver Disease

  1. Garrison RN, Cryer HM, Howard DA, Polk HC Jr. Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Ann Surg. 1984;199:648-655.PubMedCrossRefGoogle Scholar
  2. Kim JJ, Dasika NL, Yu E, Fontana RJ. Cirrhotic patients with a transjugular intrahepatic portosystemic shunt undergoing major extrahepatic surgery. J Clin Gastroenterol. 2009;43:574-579.PubMedCrossRefGoogle Scholar
  3. Mansour A, Watson W, Shayani V, Pickleman J. Abdominal operations in patients with cirrhosis: still a major surgical challenge. Surgery. 1997;122:730-735; discussion 735–736.PubMedCrossRefGoogle Scholar
  4. Rice HE, O’Keefe GE, Helton WS, Johansen K. Morbid prognostic features in patients with chronic liver failure undergoing nonhepatic surgery. Arch Surg. 1997;132:880-885.PubMedGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2011

Authors and Affiliations

  1. 1.Department of Graduate Medical EducationAtlanta Medical CenterAtlantaUSA
  2. 2.Department of MedicineMedical College of GeorgiaAugustaUSA

Personalised recommendations